MyoKardia Profile

USD 0.05  0.0927%

MyoKardia exotic insider transaction detected

MyoKardia Inc insider trading alert for general transaction of common stock by Third Rock Ventures Iii Lp, the corporate stakeholder, on January 5, 2018. This event was filed by Myokardia Inc with SEC on 2018-01-05. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

MyoKardia Summary

MyoKardia Inc (MYOK) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 77 people. MyoKardia is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 1.93 B. MyoKardia Inc has 35.74 M outstanding shares of which 1.55 M shares are now shorted by private and institutional investors with about 4.63 trading days to cover. MyoKardia currently holds about 247.18 M in cash with 10.3 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.92.
Check MyoKardia Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected MyoKardia Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

MyoKardia Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 20% 
Equity ratings for MyoKardia Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
MyoKardia, Inc., a clinical stage biopharmaceutical company, engages in discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameMyoKardia Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business AddressMyoKardia, Inc.South San Francisco, CA
CIK Number01552451.0
IndustryPharmaceutical Products
Contact Number650 741 0900
CurrencyUSD - US Dollar


MyoKardia Analyst Recommendations
Target PriceAdvice# of Analysts
26.67Strong Buy3Odds
MyoKardia Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
MyoKardia Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


MyoKardia Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.31March 17, 2017
MyoKardia Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate